From Red Flags to Referral: A Closer Look at ILD & Lung Cancer

CAN-eng

$0

free

Mainpro+

30 min

Oncology,Respirology

0.5 Credits

Take this Course
LEARN MORE

Course Description

Globally, a rising number of people are diagnosed with interstitial lung disease (ILD) and lung cancer each year. Of particular significance is the number of people suffering from these diseases without a diagnosis, resulting in a decreased quality of life and prognosis. This program aims to help clinicians effectively recognize subtle but important warning signs of ILD and lung cancer, conduct appropriate initial investigations, and refer patients promptly to pulmonology/respirology and/or thoracic surgery. The overall goal is to support clinicians to reduce diagnostic delays and improve outcomes. 

This program has received an unrestricted educational grant or in-kind support from Boehringer Ingelheim.

Course Details

Expiry Date: 2027-01-06
Professions: Physician

Faculty

  • Stephanie Snow, MD, FRCPC
  • Nicole Schneider-MacRae, MD, FRCPC
  • Christine Palmay, MD, CCFP, FCFP
  • Jacques Bouchard, MD, LMCC, CCFP, C.M.

Accreditation

This activity meets the certification criteria of the College of Family Physicians of Canada and the Quebec College of Family Physicians, a continuing professional development accrediting organization recognized by the Collège des médecins du Québec and has been approved for up to 0.5 Mainpro+® Certified Activity credit(s).

Cert+ Program ID#: 302894-001

Learning Objectives

Upon completion of this continuing education program, participants will be better able to:​

  • Recognize early warning signs and symptoms that may indicate serious respiratory conditions, like interstitial lung disease (ILD) or lung cancer
  • Order appropriate diagnostic tests for patients presenting with respiratory symptoms that may indicate ILD or lung cancer
  • Initiate timely referrals for patients who present with warning signs for ILD or lung cancer to avoid diagnostic delays
Take this Course